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ABSTRACT
Influenza epidemics arise through the acquisition of
viral genetic changes to overcome immunity from
previous infections. An increasing number of com-
plete genomes of influenza viruses have been
sequenced in Asia in recent years. Knowledge
about the genomes of the seasonal influenza viruses
from different countries in Asia is valuable for mon-
itoring and understanding of the emergence, migra-
tion and evolution of strains. In order to make full
use of the wealth of information from such data,
we have developed an integrated user friendly rela-
tional database, Influenza Sequence and Epitope
Database (ISED), that catalogs the influenza
sequence and epitope information obtained in Asia.
ISED currently hosts a total of 13020 influenza A and
2984 influenza B virus sequence data collected in 17
countries including 9 Asian countries, and a total of
approximately 545 amantadine-resistant influenza
virus sequences collected in Korea. ISED provides
users with prebuilt application tools to analyze
sequence alignment and different patterns and
allows users to visualize epitope-matching struc-
tures, which is freely accessible at http://influenza.-
korea.ac.kr and http://influenza.cdc.go.kr.
INTRODUCTION
Inﬂuenza is one of the most important respiratory infec-
tious diseases of humans. It is estimated that inﬂuenza is
responsible for 250000–500000 deaths annually (1). The
1918 pandemic resulted in the deaths of 20–50 million on a
global scale, which was one of the most devastating dis-
ease outbreaks in human history (2). Inﬂuenza viruses of
the family Orthomyxoviridae contain eight single-stranded
negative-sense RNA molecules which encode a total of 11
proteins. Three antigenically distinct virus types—A, B
and C—circulate in human populations (3). Antigenic
drift of the viruses makes the existing vaccines ineﬀective
and antigenic shift creates new strains which may cause
worldwide pandemic. Genome sequences of currently cir-
culating virus isolates are important sources of informa-
tion about inﬂuenza. Recent developments in viral
genome sequencing, antigenic mapping and epidemiologi-
cal modeling are greatly improving our knowledge of the
evolution of human inﬂuenza virus (4–6). However, many
aspects of the evolutionary and epidemiological dynamics
of inﬂuenza viruses are still far from complete.
Signiﬁcant eﬀorts have been made to build public
resources of inﬂuenza viruses, such as the Inﬂuenza
Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/
FLU/FLU.html) at the National Center for Biotechnol-
ogy Information (NCBI), the Inﬂuenza Sequence Data-
base at Los Alamos National Laboratory, the Inﬂuenza
Virus Database (http://inﬂuenza.genomics.org.cn) at the
Beijing Institute of Genomics and the BioHealthBase
Bioinformatics Resource Center (http://www.biohealth
base.org) (7–10). An increasing number of genomes of
inﬂuenza viruses have been sequenced in Asia in recent
years. Southern China has long been considered a poten-
tial epicenter for emergence of pandemic inﬂuenza viruses
(11) and becomes one of the major foci for viral surveil-
lance. Tropical regions may function as permanent mixing
pools for viruses from around the world, providing ideal
source populations because of extended viral transmission
(12). Knowledge about the genomes of the seasonal
inﬂuenza viruses from diﬀerent countries in Asia is valu-
able for monitoring and understanding of the evolution
and migration of strains. Since 1968, Korea National
Institute of Health (KNIH) has performed inﬂuenza
virus isolation as part of the World Health Organization’s
inﬂuenza surveillance network. In 2000, the Korean
Inﬂuenza Surveillance Scheme was established as an
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involving public health centers and private clinics (13).
Sentinel physicians report cases of inﬂuenza-like illness
weekly and forward specimens to KNIH for virus isola-
tion and characterization. KNIH has sequenced the iso-
lates of inﬂuenza viruses collected in Korea, which have
been registered to GenBank at the NCBI.
New insights into immunity initiated by host–pathogen
interaction are changing the way we think about patho-
genesis of inﬂuenza. The immune response to inﬂuenza
virus infection is directed against various epitopes of anti-
gens. Two important surface glycoproteins hemagglutinin
(HA) and neuraminidase (NA) mutate at high frequencies
under the strong selective pressure of the host’s immune
system (14). Epitopes can be used to monitor immune
response and a single amino acid mutation at the key
residue of the epitope is frequently suﬃcient to cause an
antigenic change (15). High-level antiviral drug resistance
can also be conferred by single amino acid substitutions
(16). Over the years, inﬂuenza antiviral drug resistance has
grown rapidly despite the eﬃcacy of the drugs comparable
to that of vaccines. In order to leverage the wealth of
information from such data, we have developed an inte-
grated user friendly relational database, Inﬂuenza
Sequence and Epitope Database (ISED), particularly
focusing on the genomes of the seasonal inﬂuenza viruses
from Asian countries. We have added value by implement-
ing a suite of bioinformatics tools that can be used to
analyze and visualize the inﬂuenza data. This freely acces-
sible resource will augment inﬂuenza research and contrib-
ute to improved public heath.
OVERVIEW OF THE DATABASE
ISED was designed to collect, store and provide sequence
information on inﬂuenza viruses including drug-resistant
strains, conjoined to research tools for sequence pattern
and epitope structural analyses of the data. At present,
ISED includes information on 16004 inﬂuenza sequences
(13 020 inﬂuenza A and 2984 inﬂuenza B viruses) including
those from nine Asian countries (China, Japan, Korea,
Malaysia, Philippines, Singapore, Taiwan, Thailand and
Vietnam) (Table 1). It also hosts 545 drug-resistant inﬂu-
enza sequences against amantadine collected in Korea
(Table 2). No drug-resistant inﬂuenza isolates were found
inKoreaagainstoseltamivirandzanamivir.Inﬂuenzavirus
sequences collected in Korea are registered and will be
registeredtoGenBankattheNCBIimmediatelyuponpub-
lication (currently an additional 184 segment sequences as
well as 545 drug-resistant sequences). Those of other coun-
tries are collected by searching from NCBI GenBank data-
base. ISED alsocontainsatotal of179Tcell epitopes and5
antibody epitopes experimentally determined or curated
from scientiﬁc literature, useful for epitope matching.
The data are updated on a regular basis by a curation
team, composed of researchers at the Center for Infectious
Diseases at KNIH and in Korea University, in order to
ensure a consistently high data quality. The data in ISED
is open and freely accessible to the general public, which is
one of the chief goals of ISED to oﬀer users easy Web
access and graphical user interfaces. ISED is a part of the
National BioBank project intended to integrate a frame-
work for identifying, collecting, distributing and manag-
ing of biomateirals, which is being developed at KNIH.
DATABASE DESIGN AND CONTENTS
The virus sequences in ISED are categorized
into tables according to countries, each of which is char-
acterized by a number of attributes: strain name, target
host, virus type, virus subtype or lineage (B type only),
RNA segment, amino acid sequence, start number of
amino acid sequence, aligned amino acid sequences,
NCBI accession number (amino acid sequence),
Table 1. Current number of inﬂuenza virus sequence data in ISED
Nation Host Segment
a Total
PB2 PB1 PA HA NP NA M1/M2 NS1/NS2
Australia Human 103/4 93/4 211/4 259/70 106/4 219/9 0 0 991/95
Canada Human 4/3 4/3 4/3 7/4 2/3 49/5 0 0 70/21
China Human 32/22 33/22 32/23 810/164 45/22 343/49 78/42 67/40 1440/384
France Human 1/1 1/1 1/1 205/6 1/1 33 0 0 242/10
Germany Human 33/0 17/0 28/0 116/1 33/0 35/0 0 0 262/1
Italy Human 0/2 0/1 0/2 91/86 0/2 4/40 0 0 95/133
Japan Human 14/40 14/40 14/40 655/200 15/48 15/52 32/89 29/109 788/615
Korea Human 3/0 3/0 3/0 265/81 3/0 41/5 48/2 6/2 372/90
Malaysia Human 0 0 0 59/22 0 0 0 0 59/22
Philippines Human 0 0 0 66/60 0 0 0 0 66/60
Singapore Human 0 0 0 86/13 0 0 0 0 86/13
Spain Human 0/1 0/1 0/1 72/23 0/1 6/3 0 0 78/30
Taiwan Human 6/2 6/2 6/2 254/336 6/2 6/2 12/12 11/11 307/354
Thailand Human 0/6 0/6 0/6 124/70 0/6 0/12 0/12 0/11 124/129
USA Human 1277/120 1062/120 1386/117 1799/272 1347/120 908/264 0 0 7779/1013
United Kingdom Human 12/1 11/1 8/1 123/9 15/1 15/1 0 0 184/14
Vietnam Human 0 0 0 77/0 0 0 0 0 77/0
Total 1485/202 1244/201 1693/200 5068/1417 1573/210 1674/442 170/149 113/163 13020/2984
aInﬂuenza virus type A/B.
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aligned nucleotide sequences, NCBI accession number
(nucleotide sequence), reference, author list, isolated
region, isolated year and isolated season, followed by osel-
tamivir/zanamivir-resistant and amantadine-resistant viral
sequences if available (data not shown). Reference, one of
the attributes, is linked to the PubMed abstract and in
some instances to the full text of the article if the journal
is available online. Target host and isolated region
(nation) tables have one-to-many relationships with the
virus sequence table, which are frequently used to extract
statistical information. Both vaccine and drug-resistant
strain sequences are included in the sequence table. The
sequences of 46 vaccine strains (9 strains in A/H1N1, 23 in
A/H3N2 and 14 in B) are separately grouped as a vaccine
strain table. Since 2002, drug-susceptibility surveillance
has been routinely undertaken in the characterization of
inﬂuenza virus isolates submitted to KNIH. Earlier sur-
veillance showed a low incidence of resistance to amanta-
dine (below 10%). However, as of August 2008, 156
amantadine-resistant inﬂuenza sequences in A/H1N1
and 389 amantadine-resistant strain sequences in A/
H3N2 were collected in Korea (Table 2).
Epitope data were obtained from the Immune Epitope
Database and Analysis Resource (IEDB) (http://www.
immuneepitope.org/home.do) with 14 reference strain
data (15). The database ﬁelds in the epitope data table
contain epitope residue, start residue number of epitope,
number of residues (only B cell response), virus strain,
source protein, protein sequence, start residue number of
source protein, epitope type (T cell, B cell response or
MHC binding), NCBI accession number of source protein
and reference. A reference strain table has one-to-many
relationship with the epitope table (data not shown).
DATA RETRIEVAL AND TOOLKIT
ISED consists of a framework for advanced web-based
retrieval, analysis and visualization of related inﬂuenza
data: sequence browse, sequence analysis and epitope
matching arranged in one Oracle schema (17). Sequence
data can be retrieved eﬃciently through establishment of
the sequence browse mode (Figure 1). Users can combine
various options, such as virus type, nation, host, RNA
segment, subtype and collection year. The website then
provides access to individual inﬂuenza sequence records
characterized by a number of database ﬁelds, such as
accession number, sequence length, virus type, target
host, RNA segment, subtype, collected nation and year,
virus name and potential N-glycosylation site. The
sequence browse results are displayed in chronological
order and can also be sorted by column by clicking
the table header. Two diﬀerent search options are pro-
vided: individual and collective selection. The amino
acid sequences of the selected strains in the displayed list
can be retrieved in a separate window by clicking the
‘View fasta format’ button, or can be easily downloaded
(Figure 1). Users can prepare an input data by clicking
‘Sequence alignment’ and conduct multiple sequence
alignment by direct submission or upload a ﬁle of the
chosen sequences to CLUSTALW tool of EBI (18).
Later, a user’s past search history can be located and
accessed by the Web server. Drug-resistant inﬂuenza
sequences can also be retrieved in a sequence browse
mode, where alignment or diﬀerence patterns of selected
resistant sequences can be examined (Figure 2A).
The contents of the epitope resource can be searched via
user-friendly interface. For epitope matching, users can
select virus subtype and reference strains in the
reference table containing database ﬁelds, such as virus
strain, collected area, virus type and target host. Search
can query via one of strains and locations which can be
selected from pull-down menus, or users can upload and
submit their own sequences (Figure 2B). Details of epitope
information can be viewed with the strings of amino acid
sequences highlighted either in green or blue for antibody
or T cell epitopes, respectively. More detailed information
can be retrieved by clicking each epitope segment.
Table 2. Current number of drug-resistant virus data in Korea
Amantadine-resistant inﬂuenza virus strains in Korea
Season A/H1N1 A/H3N2
Total number
of isolates
Resistant/
tested
Percent
resistance
Total number
of isolates
Resistant/
tested
Percent
resistance
2003–2008
a 1858 156/302 51.7 4418 389/684 56.9
Oseltamivir/zanamivir-resistant inﬂuenza virus strains in Korea
Season A/H1N1 A/H3N2 B Percent
resistance
Total number
of isolates
Resistant/
tested
Total number
of isolates
Resistant/
tested
Total number
of isolates
Resistant/
tested
2002–2007
b 1276 0/105(60) 4938 0/683(244) 1434 0/146(32) 0
aThe 2008 data included the number of isolates determined by the 7th week.
bThe values in parentheses represent the number of isolates against zanamivir.
Nucleic Acids Research, 2009,Vol. 37,Database issue D425The epitope 3D structure is visualized using an interactive
Jmol (http://www.jmol.org), which is superimposed on
an HA tertiary structure model provided by the Protein
Data Bank (19). Users can also easily examine matching
frequencies between the selected strain and reference
strains.
DATA ANALYSIS
ISED allows access to sequence analysis tools by clicking
‘Sequence analysis’ on the top menu bar. Users can select
virus sequence resources via a graphical interface accord-
ing to virus type, collected region (nation) and RNA
Figure. 1. Snapshots showing the interrelation of data retrieval tools in ISED. Users can access the data through search options and the results can
be selectively saved. The results can be subjected to further analysis, such as multiple sequence alignment.
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duct sequence alignment or sequence diﬀerence by clicking
the ‘alignment’ or ‘diﬀerence’ button. Users can also com-
bine sequences from diﬀerent sources. On the result page,
the alignment can be viewed with color-coded amino
acids, so that viral mutations can be seen as changes in
color when scanning from the N- to C-terminus along the
sequence (Figure 3B). Diﬀerence can be also viewed in a
separate full-screen window with color coding, where the
amino acids with mutations are displayed with additional
Figure 2. The mutant and epitope analysis tools (A) Mutant sequence search, alignment and diﬀerence patterns are shown. (B) Epitope sequence and
structure analysis showing sequence alignment with reference strains, sequence-matching frequency and an epitope 3D conformation superimposed
on a HA structure viewed with Jmol.
Nucleic Acids Research, 2009,Vol. 37,Database issue D427information of mutation frequencies as well as antigenic
sites. Notably, the sequence analysis also includes a vac-
cine strain tool, with which users can conduct either
sequence diﬀerence or sequence comparison with vaccine
strains (Figure 3C). Sequence diﬀerence among vaccine
strains returns a result of list of the diﬀerences in
amino acid sequences among the vaccine strains
with information of mutation frequencies as well as
Figure 3. Snapshots showing the interrelation of ISED sequence analysis tools. (A) Users can select sequences or combine sequences from diﬀerent
sources and (B) conduct sequence alignment or sequence comparisons. (C) Sequence diﬀerences with vaccine strains are displayed in a separate
window with color coding.
D428 Nucleic Acids Research, 2009, Vol. 37, Databaseissueantigenic sites. More interestingly, the results of sequence
comparison between a sample of circulating strain and
vaccine strains can be illustrated by the changes in color
patterns against vaccine strains (the lighter the color, the
lower the diﬀerence). Thus, ISED provides a convenient
tool for evaluating the relative closeness of the currently
circulating strain against known vaccine strains. Users can
then export the results as an Excel or Word ﬁle.
FUTURE DIRECTIONS
It is still unclear what features of the inﬂuenza viruses
are responsible for the global spread and more speciﬁ-
cally how the dominant strain is derived. For instance,
A/Fujian/411/02 collected in southern China is believed
to cause signiﬁcant outbreaks in China, Japan and
Korea in 2002 and spread worldwide during the successive
winter season of 2003–2004. The main challenge in the
future is to keep ISED up to date with the growing
number of complete inﬂuenza virus sequences experimen-
tally veriﬁed and registered to other databases such as
NCBI GenBank. We will thus implement text mining sup-
port for database curation in the near future. Toward this
goal, a network of inﬂuenza expert groups at the Center
for Infectious Diseases at KNIH and at Korea University
and advisory committee outside KNIH will coordinate
validation of new virus strains.
Another challenge is to provide ISED with regional
epidemiological features of drug-resistant viruses.
Amantadine and rimantadine have been used for the pre-
vention and treatment of inﬂuenza A virus infection for
>30 years (20). Widespread use of antiviral drugs relying
on pandemic stockpiles has the potential to promote emer-
gence of resistant strains of which the epidemiological
surveillance is a key to monitor and control. Open sharing
of the resistant viral genome information has become
increasingly important in preventing and controlling the
spread of the resistant viruses. In addition, an antiviral
drug resistance analysis tool can be developed and
linked to the records in the database, which provides
users to analyze inﬂuenza sequences for mutations
known to confer drug resistance or sensitivity.
The recent H5N1 outbreaks in Asia and a worst out-
break in Korea in 2008 have spurred our interest in sur-
veillance among wild and domestic birds. Avian inﬂuenza
surveillance may provide early warning signals for any
possible introduction of avian viruses in new regions.
Importantly, a large number of genome sequences of
avian inﬂuenza viruses are accumulated in Asia. Given
the regions potential as an epicenter for emergence of
new inﬂuenza virus strains, we particularly intend to
extend the ISED platform to enable epidemiological mon-
itoring of avian inﬂuenza virus sequences.
USER MANAGEMENT
The ISED management system allows users to access the
inﬂuenza virus sequence database without registration,
except for drug-resistant virus sequence data. However,
user registration is required for adding and editing
database contents, and user support can be obtained by
e-mailing graduate@korea.ac.kr or khkim@korea.ac.kr.
Readers are encouraged to contact us if they wish to pro-
vide new data for inclusion in ISED, assist with curation
or have any suggestions for improvements.
IMPLEMENTATION
ISED was developed as a relational database using Oracle
10g applications (14) on the Windows operating system.
Two open source programs, the Apache HTTP Server and
Apache Tomcat, were used as HTTP server and servlet
container for web service, respectively. Perl scripts were
used to provide common gateway interface for sequence
alignment using ClustalW, and Java applet was used
to link Jmol for displaying 3D models. ISED can be
publicly accessed from any Web browser at http://
inﬂuenza.korea.ac.kr.
ACKNOWLEDGEMENTS
We wish to acknowledge the technical support from
Mr C. H. Gong at the Department of Biotechnology &
Bioinformatics and Mr J. H. Yeom of the E-Front, Seoul,
Korea.
FUNDING
Korea National Institute of Health (2008-E00179);
BioGreen 21 program grant (20080401-034-008) and the
Basic Research Program of the Korea Science &
Engineering Foundation. Funding for open access
charge: Korea National Institute of Health.
Conﬂict of interest statement. None declared.
REFERENCES
1. Stohr,K. (2002) Inﬂuenza – WHO cares. Lancet Infect. Dis.,
2, 517.
2. Taubenberger,J.K., Reid,A.H., Janczewski,T.A. and Fanning,T.G.
(2001) Integrating historical, clinical and molecular genetic data in
order to explain the origin and virulence of the 1918 Spanish
inﬂuenza cirus. Phil. Trans. R. Soc. Lond. B Biol. Sci.,
356, 1857–1859.
3. Cox,N.J. and Subbarao,K. (2000) Global epidemiology of inﬂuenza:
past and present. Ann. Rev. Med., 51, 407–421.
4. Ghedin,E., Sengamalay,N.A., Shumway,M., Zaborsky,J.,
Feldblyum,T., Subbu,V., Spiro,D.J., Sitz,J., Koo,H., Bolotov,P.
et al. (2005) Large-scale sequencing of human inﬂuenza reveals the
dynamic nature of viral genome evolution. Nature, 437, 1162–1166.
5. Smith,D.J., Lapedes,A.S., de Jong,J.C., Bestebroer,T.M.,
Rimmelzwaan,G.F., Osterhaus,A.D. and Fouchier,R.A. (2004)
Mapping the antigenic and genetic evolution of inﬂuenza virus.
Science, 305, 371–376.
6. Russel,C.A., Jones,T.C., Barr,I.G., Cox,N.J., Garten,R.J.,
Gregory,V., Gust,I.D., Hampson,A.W., Hay,A.J., Hurt,A.C. et al.
(2008) The global circulation of seasonal inﬂuenza A (H3N2)
virusese. Science, 320, 340–346.
7. Bao,Y., Bolotov,P., Dernovoy,D., Kiryutin,B., Zaslavsky,L.,
Tatusova,T., Ostell,J. and Lipman,D. (2008) The inﬂuenza virus
resource at the national center for biotechnology information.
J. Virol., 82, 596–601.
8. Macken,C., Lu,H., Goodman,J. and Boykin,L. (2001) The value of
a database in surveillance and vaccine selection. In
Nucleic Acids Research, 2009,Vol. 37,Database issue D429Osterhaus,A.D.M.E., Cox,N. and Hampson,A.W. (eds), Options
for the Control of Inﬂuenza IV. Elsevier Science, Amsterdam,
pp. 103–106.
9. Chang,S., Zhang,J., Liao,X., Zhu,X., Wang,D., Zhu,J., Feng,T.,
Zhu,B., Gao,G.F., Wang,J. et al. (2007) Inﬂuenza virus database
(IVDB): an integrated information resource and analysis platform
for inﬂuenza virus research. Nucl. Acids Res., 35, D376–D380.
10. Squires,B., Macken,C., Garcia-Sastre,A., Godbole,S., Noronha,J.,
Hunt,V., Chang,R., Larsen,C.N., Klem,E., Biersack,K. et al. (2008)
BioHealthBase: informatics support in the elucidation of inﬂuenza
virus host-pathogen interactions and virulence. Nucleic Acids Res.,
36, D497–D503.
11. Webster,R.G., Bean,W.J., Gorman,O.T., Chambers,T.M. and
Kawaoka,Y. (1992) Evolution and ecology of inﬂuenza A viruses.
Microbiol. Rev., 56, 152–179.
12. Wong,C.M., Yang,L., Chan,K.P., Leung,G.M., Chan,K.H.,
Guan,Y., Lam,T.H., Hedley,A.J. and Peiris,M. (2006) Inﬂuenza-
associated weekly hospitalization in a subtropical city. PLoS Med.,
3, 485–491.
13. Lee,J.S., Shin,K.C., Na,B.K., Lee,J.Y., Kang,C., Kim,J.H.,
Park,O., Jeong,E.K., Lee,J.K., Kwon,J.W. et al. (2007) Inﬂuenza
surveillance in Korea: establishment and ﬁrst results of an
epidemiological and virological surveillance scheme. Epidemio.
Infect., 135, 1117–1123.
14. Daly,J.M., Wood,J.M. and Robertson,J.S. (1988) Co-circulation
and divergence of human inﬂuenza viruses. In Nicholson, K.G.,
Webster,R.G. and Hay,A.J. (eds), Textbook of Inﬂuenza. Blackwell
Science, Oxford, pp. 168–177.
15. Bui,H., Peters,B., Assarsson,E., Mbawuike,I. and Sette,A. (2007)
Ab and T cell epitopes of inﬂuenza A virus, knowledge and
opportunities. Proc. Natl Acad. Sci. USA, 104, 246–251.
16. Beigel,J.H., Farrar,J., Han,A.M., Hayden,F.G., Hyer,R.,
de Jong,M.D., Lochindarat,S., Nguyen,T.K., Nguyen,T.H.,
Tran,T.H. et al. (2005) Avian inﬂuenza A (H5N1) infection
in humans. N. Engl. J. Med., 353, 1374–1385.
17. Stephens,S.M., Chen,J.Y., Davidson,M.G., Thomas,S. and
Trute,B.M. (2005) Oracle database 10g: a platform for BLAST
search and regular expression pattern matching in life sciences.
Nucleic Acids Res., 33, D675–D679.
18. Thompson,J.D., Higgins,D.G. and Gibson,T.J. (1994)
CLUSTALW: improving the sensitivity of progressive multiple
sequence alignment through sequence weighting, position-speciﬁc
gap penalties and weight matrix choice. Nucleic Acids Res.,
22, 4673–4680.
19. Berman,H.M., Westbrook,J., Feng,Z., Gilliland,G., Bhat,T.N.,
Weissig,H., Shindyalov,I.N. and Bourne,P. (2000) The protein data
bank. Nucleic Acids Res., 28, 235–242.
20. Bright,R.A., Medina,M.J., Xu,X., Perez-Oronoz,G., Wallis,T.R.,
Davis,X.M., Povinelli,L., Cox,N.J. and Klimov,A.I. (2005)
Incidence of adamantine resistance among inﬂuenza A (H3N2)
virusese isolated worldwide from 1994 to 2005: a cause for concern.
Lancet, 366, 1175–1181.
D430 Nucleic Acids Research, 2009, Vol. 37, Databaseissue